Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $1.148B (97.5% shares, 2.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VERONA PHARMA PLC | 625,000 | $66.69M | 5.8% | $18.37 | — | SPONSORED ADS | 925050106 |
| INSM | INSMED INC | 450,000 | $64.8M | 5.6% | $72.50 | +69.0% | COM PAR $.01 | 457669307 |
| SPY | SPDR S&P 500 ETF TR | 84,490 | $56.29M | 4.9% | $666.18 | — | TR UNIT | 78462F103 |
| XENE | XENON PHARMACEUTICALS INC | 1,400,000 | $56.21M | 4.9% | $39.23 | -10.2% | COM | 98420N105 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 115,000 | $52.75M | 4.6% | $216.49 | +72.3% | COM | 558868105 |
| APGE | APOGEE THERAPEUTICS INC | 1,173,426 | $46.62M | 4.1% | $37.62 | +1.5% | COM | 03770N101 |
| ACLX | ARCELLX INC | 500,000 | $41.05M | 3.6% | $44.92 | +60.3% | COMMON STOCK | 03940C100 |
| ALKS | ALKERMES PLC | 1,250,000 | $37.5M | 3.3% | $26.24 | +7.4% | SHS | G01767105 |
| NUVL | NUVALENT INC | 384,417 | $33.24M | 2.9% | $72.88 | +8.5% | COM | 670703107 |
| ABVX | ABIVAX SA | 360,000 | $30.56M | 2.7% | $63.05 | — | SPONSORED ADS | 00370M103 |
| INSM | INSMED INC | 205,000 | $29.52M | 2.6% | $72.50 | +69.0% | Call | 457669307 |
| MLYS | MINERALYS THERAPEUTICS INC | 750,000 | $28.44M | 2.5% | $11.77 | +83.8% | COM | 603170101 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $28.28M | 2.5% | $8.35 | — | SPONSORED ADS | 881624209 |
| — | MERUS N V | 285,769 | $26.91M | 2.3% | $82.92 | — | COM | N5749R100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,107,162 | $26.85M | 2.3% | $12.11 | — | SPONSORED ADS | 152309100 |
| LXEO | LEXEO THERAPEUTICS INC | 3,870,527 | $25.7M | 2.2% | $3.84 | +26.0% | COM | 52886X107 |
| TRVI | TREVI THERAPEUTICS INC | 2,800,000 | $25.62M | 2.2% | $5.69 | +31.7% | COM | 89532M101 |
| SYRE | SPYRE THERAPEUTICS INC | 1,419,299 | $23.79M | 2.1% | $18.18 | -10.3% | COM NEW | 00773J202 |
| RZLT | REZOLUTE INC | 2,100,000 | $19.74M | 1.7% | $2.30 | +188.9% | COM NEW | 76200L309 |
| CYTK | CYTOKINETICS INC | 350,000 | $19.24M | 1.7% | $41.20 | 0.0% | COM NEW | 23282W605 |
| ORKA | ORUKA THERAPEUTICS INC | 959,180 | $18.45M | 1.6% | $21.60 | -31.4% | COM | 687604108 |
| QURE | UNIQURE NV | 300,000 | $17.51M | 1.5% | $16.30 | +11.4% | SHS | N90064101 |
| WVE | WAVE LIFE SCIENCES LTD | 2,100,000 | $15.37M | 1.3% | $7.10 | +13.9% | SHS | Y95308105 |
| — | PROTAGONIST THERAPEUTICS INC | 220,600 | $14.65M | 1.3% | $66.43 | — | COM | 74366e102 |
| EXEL | EXELIXIS INC | 350,000 | $14.46M | 1.3% | — | — | Put | 30161Q104 |
| SLNO | SOLENO THERAPEUTICS INC | 200,000 | $13.52M | 1.2% | $74.14 | 0.0% | COM | 834203309 |
| AVTX | AVALO THERAPEUTICS INC | 1,006,217 | $12.79M | 1.1% | $9.58 | -10.3% | COM NEW | 05338F306 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 310,000 | $12.71M | 1.1% | $53.71 | -24.0% | COM | G31249108 |
| — | KARYOPHARM THERAPEUTICS INC | 15,250,000 | $12.46M | 1.1% | $0.69 | — | NOTE 3.000%10/1 | 48576UAA4 |
| VTYX | VENTYX BIOSCIENCES INC | 3,924,415 | $12.2M | 1.1% | $1.62 | +64.0% | COM | 92332V107 |
| ROIV | ROIVANT SCIENCES LTD | 800,000 | $12.1M | 1.1% | $11.60 | +6.7% | SHS | G76279101 |
| TVTX | TRAVERE THERAPEUTICS INC | 500,000 | $11.95M | 1.0% | $19.81 | -5.1% | COM | 89422G107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 262,100 | $10.31M | 0.9% | $25.56 | 0.0% | COM | 252828108 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,000,000 | $9.81M | 0.9% | $2.79 | +1.6% | COM SHS | 877619106 |
| ERAS | ERASCA INC | 4,285,787 | $9.343M | 0.8% | $1.90 | -16.4% | COM | 29479A108 |
| NRIX | NURIX THERAPEUTICS INC | 967,620 | $8.941M | 0.8% | $10.44 | -0.5% | COM | 67080M103 |
| VERA | VERA THERAPEUTICS INC | 303,330 | $8.815M | 0.8% | $31.26 | -26.0% | CL A | 92337R101 |
| — | ENLIVEN THERAPEUTICS INC | 400,000 | $8.188M | 0.7% | $20.47 | — | COM | 29337e102 |
| — | TRAVERE THERAPEUTICS INC | 7,000,000 | $7.927M | 0.7% | $0.90 | — | NOTE 2.250% 3/0 | 89422GAA5 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 275,000 | $7.821M | 0.7% | $17.93 | +33.7% | ORDINARY SHARES | N62509109 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 300,000 | $7.761M | 0.7% | $23.17 | 0.0% | COM NEW | 15117B202 |
| PRQR | PROQR THRAPEUTICS N V | 3,600,000 | $7.668M | 0.7% | $2.92 | -25.2% | SHS EURO | N71542109 |
| TARS | TARSUS PHARMACEUTICALS INC | 125,000 | $7.429M | 0.6% | $49.23 | 0.0% | COM | 87650L103 |
| SMMT | SUMMIT THERAPEUTICS INC | 350,000 | $7.231M | 0.6% | — | — | Put | 86627T108 |
| AKBA | AKEBIA THERAPEUTICS INC | 2,450,000 | $6.689M | 0.6% | $2.43 | +36.7% | COM | 00972D105 |
| MNPR | MONOPAR THERAPEUTICS INC | 79,483 | $6.491M | 0.6% | $37.36 | +19.6% | COM NEW | 61023L207 |
| EXEL | EXELIXIS INC | 150,000 | $6.195M | 0.5% | — | — | Call | 30161Q104 |
| ZURA | ZURA BIO LTD | 1,274,351 | $5.518M | 0.5% | $2.10 | -14.5% | CLASS A ORD SHS | G9TY5A101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 250,000 | $5.395M | 0.5% | $16.46 | +9.6% | COM | 92790C104 |
| SVRA | SAVARA INC | 1,500,000 | $5.355M | 0.5% | $2.88 | +2.8% | COM | 805111101 |
| NTLA | INTELLIA THERAPEUTICS INC | 300,000 | $5.181M | 0.5% | — | — | Call | 45826J105 |
| IMVT | IMMUNOVANT INC | 300,000 | $4.836M | 0.4% | $16.19 | 0.0% | COM | 45258J102 |
| — | OMEROS CORP | 5,525,000 | $4.713M | 0.4% | $0.78 | — | NOTE 9.500% 6/1 | 682143AK8 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $4.67M | 0.4% | $39.15 | 0.0% | COM | 76155X100 |
| OMER | OMEROS CORP | 1,133,900 | $4.649M | 0.4% | — | — | Put | 682143102 |
| PCVX | VAXCYTE INC | 125,000 | $4.503M | 0.4% | $38.48 | -13.9% | COM | 92243G108 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 245,000 | $4.192M | 0.4% | $6.02 | — | *W EXP 99/99/999 | N62509117 |
| — | CELCUITY INC | 3,000,000 | $3.998M | 0.3% | $1.33 | — | NOTE 2.750% 8/0 | 15102KAA8 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 350,000 | $3.756M | 0.3% | $10.07 | +5.1% | CL A ORD SHS | G70077105 |
| INSP | INSPIRE MED SYS INC | 50,000 | $3.71M | 0.3% | $101.25 | 0.0% | COM | 457730109 |
| OVID | OVID THERAPEUTICS INC | 2,650,000 | $3.445M | 0.3% | $0.80 | +7.9% | COM | 690469101 |
| BBIO | BRIDGEBIO PHARMA INC | 65,000 | $3.376M | 0.3% | $28.52 | +71.0% | COM | 10806X102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 25,000 | $3.295M | 0.3% | $108.63 | +10.4% | SHS USD | G50871105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 75,000 | $3.124M | 0.3% | $27.88 | +14.7% | COM | 22663K107 |
| MBX | MBX BIOSCIENCES INC | 165,000 | $2.888M | 0.3% | $13.37 | 0.0% | COM | 55287L101 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1,750,000 | $2.853M | 0.2% | $4.28 | — | SPON ADS | 05280R100 |
| OCUL | OCULAR THERAPEUTIX INC | 239,000 | $2.794M | 0.2% | $11.96 | 0.0% | COM | 67576A100 |
| OACCU | OAKTREE ACQUISITION CORP III | 250,000 | $2.66M | 0.2% | $10.15 | — | UNIT 10/04/2029 | G6717R120 |
| CLYM | CLIMB BIO INC | 1,300,000 | $2.613M | 0.2% | $3.30 | -43.7% | COM | 28658R106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 250,000 | $2.447M | 0.2% | $5.03 | +19.4% | Call | 68062P106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 250,000 | $2.447M | 0.2% | $5.03 | +19.4% | COM | 68062P106 |
| SGMT | SAGIMET BIOSCIENCES INC | 350,000 | $2.401M | 0.2% | $8.11 | 0.0% | COM SER A | 786700104 |
| — | ASTRIA THERAPEUTICS INC | 300,000 | $2.184M | 0.2% | $5.36 | — | COM | 04635X102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,000 | $2.096M | 0.2% | $336.31 | 0.0% | COM | 91307C102 |
| GERN | GERON CORP | 1,500,000 | $2.055M | 0.2% | $2.82 | -52.8% | COM | 374163103 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 450,000 | $2.025M | 0.2% | $5.55 | -29.3% | COM | 03675P102 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 727,272 | $1.804M | 0.2% | $2.76 | 0.0% | COM | 68572M106 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 300,000 | $1.77M | 0.2% | $5.44 | 0.0% | COM | 29842P105 |
| CGEM | CULLINAN THERAPEUTICS INC | 263,817 | $1.564M | 0.1% | $9.11 | -19.6% | COM | 230031106 |
| ATYR | ATYR PHARMA INC | 2,100,000 | $1.515M | 0.1% | — | — | Put | 002120202 |
| MIST | MILESTONE PHARMACEUTICALS IN | 666,666 | $1.333M | 0.1% | $1.76 | 0.0% | COM | 59935V107 |
| CMPS | COMPASS PATHWAYS PLC | 200,000 | $1.146M | 0.1% | $5.73 | — | SPONSORED ADS | 20451W101 |
| NXTC | NEXTCURE INC | 191,882 | $1.124M | 0.1% | $5.23 | 0.0% | COM NEW | 65343E207 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 157,600 | $1.031M | 0.1% | — | — | Call | 48576U205 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 300,000 | $1.029M | 0.1% | $7.43 | -51.0% | COM NEW | 46489V302 |
| ABUS | ARBUTUS BIOPHARMA CORP | 211,500 | $960K | 0.1% | — | — | Call | 03879J100 |
| — | SUTRO BIOPHARMA INC | 752,722 | $654K | 0.1% | $0.65 | — | COM | 869367102 |
| JBIO | JADE BIOSCIENCES INC | 65,317 | $564K | 0.0% | $33.31 | -75.5% | COM NEW | 008064206 |
| ENGN | ENGENE HOLDINGS INC | 77,000 | $526K | 0.0% | $3.75 | +21.5% | COM | 29286M105 |
| CNTX | CONTEXT THERAPEUTICS INC | 402,653 | $390K | 0.0% | $1.56 | -47.9% | COM | 21077P108 |
| — | REPARE THERAPEUTICS INC | 200,000 | $352K | 0.0% | $2.21 | — | COM | 760273102 |
| CBIO | CRESCENT BIOPHARMA INC. | 17,998 | $214K | 0.0% | $21.15 | -37.3% | COM | G2545C104 |
| ADGM | ADAGIO MED HLDGS INC | 80,000 | $155K | 0.0% | $4.76 | -67.4% | COM | 00534B100 |
| QTTB | Q32 BIO INC | 27,777 | $54,998 | 0.0% | $13.78 | -86.1% | COM | 746964105 |
| SPRY | ARS PHARMACEUTICALS INC | 2,500 | $25,125 | 0.0% | $14.35 | 0.0% | COM | 82835W108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $2,993 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |